Publications by authors named "Yongping Mu"

Claim this Profile
T
Total astragalus saponins enhance the anti-liver fibrosis efficacy of Numb-overexpressed hUC-MSCs through stabilizing the Numb-p53 axis.
Shi-Hao Zhang, Ming-Yan Yang, Yan-Nan Xu, Fei-Fei Xing, Jun-Yi Zhan, Yong-Ping Mu

J Ethnopharmacol· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rehmannioside D ameliorates hepatocyte apoptosis and liver fibrosis by suppressing Sirt7/p53 axis.
Yue Liang, Tian-Yu Cheng, Jia-Ying Pu, Gao-Feng Chen, Wei Liu, Yong-Ping Mu

J Ethnopharmacol· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: commentary on "Prevalence of colonoscopy-related adverse events in older adults aged over 65 years: a systematic review and meta-analysis".
Dexin Wang, Yongping Mu, Jinzhong Yu

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Numb-exon3 and full length Numb equivalently alleviate cholestatic liver fibrosis by inhibiting ductular reaction.
Yan-Nan Xu, Meng-Yao Zong, Wen Xu, Shi-Hao Zhang, Dan-Yang Wang, Yong-Ping Mu

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M1-BMDMs with Wnt5a deletion attenuate liver fibrosis by suppression of Wnt5a/Frizzled 2 axis in hepatic progenitors.
Fei-Fei Xing, Dan-Yang Wang, Yan-Nan Xu, Xin-Rui Zheng, Shi-Hao Zhang, Yong-Ping Mu

Cell Biosci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum miR-30c serves as potential biomarkers for the diagnosis and prognosis of gastric cancer.
Xiao-Yan Tian, Yong-Ping Mu

J Toxicol Environ Health A· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of anti-tumour effects of Paris polyphylla saponins via ROS: molecular mechanisms and therapeutic potentials.
Jia Liu, Yongping Mu, Ke Qi, Jiayi Li, Yang Hu

Front Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology.
Ke Qi, Yongping Mu, Yang Hu, Jiayi Li, Jia Liu

Front Cell Dev Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mA reader YTHDC2 restrains endometrial cancer progression through suppressing hedgehog signaling pathway.
Xinyan Zhang, Man Gao, Hongyun Ma, Zhao Ma, Tengqi Wang, Yongping Mu

Pathol Res Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualizing global progress and challenges in esophagogastric variceal bleeding.
De-Xin Wang, Xue-Jie Wu, Jin-Zhong Yu, Jun-Yi Zhan, Fei-Fei Xing, Yong-Ping Mu

World J Gastrointest Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic model for esophagogastric variceal rebleeding after endoscopic treatment in liver cirrhosis: A Chinese multicenter study.
Jun-Yi Zhan, Jie Chen, Jin-Zhong Yu, Fei-Peng Xu, Fei-Fei Xing, Yong-Ping Mu

World J Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier.
Linzhang Zhang, Xiaoyu Jiang, Jiewen Shi, Jianwei Zhang, Xiaoli Shi, Yongping Mu

J Ethnopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Schisantherin A protects hepatocyte via upregulating DDAH1 to ameliorate liver fibrosis in mice" [Phytomedicine, 2024, 124: 155330].
Yue Liang, Jing Fang, Xiaoxi Zhou, Zheng Zhang, Wei Liu, Yongping Mu

Phytomedicine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5.
Qun Zhou, Siqi Gao, Xiaohan Yu, Linzhang Zhang, Zheng Zhang, Yongping Mu

Phytother Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species.
Ke Qi, Jiayi Li, Yang Hu, Yiyun Qiao, Yongping Mu

Front Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic progenitor cell-originated ductular reaction facilitates liver fibrosis through activation of hedgehog signaling.
Yonghong Hu, Xinyu Bao, Zheng Zhang, Long Chen, Yue Liang, Yongping Mu

Theranostics· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease.
Feipeng Xu, Hua Zhang, Jiamei Chen, Junyi Zhan, Ping Liu, Yongping Mu

J Ethnopharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial.
Shenxin Lu, Jie Chen, Rui Zhang, Tiancheng Luo, Lili Ma, Yongping Mu

Expert Rev Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schisantherin A protects hepatocyte via upregulating DDAH1 to ameliorate liver fibrosis in mice.
Yue Liang, Jing Fang, Xiaoxi Zhou, Zheng Zhang, Wei Liu, Yongping Mu

Phytomedicine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Linzhang Zhang, Jiewen Shi, Qin Shen, Yadong Fu, Shenglan Qi, Yongping Mu

J Ethnopharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BM-MSCs overexpressing the Numb enhance the therapeutic effect on cholestatic liver fibrosis by inhibiting the ductular reaction.
Yan-Nan Xu, Wen Xu, Xu Zhang, Dan-Yang Wang, Xin-Rui Zheng, Yong-Ping Mu

Stem Cell Res Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Yanggan Jian in Hepatitis B Virus-related Decompensated Cirrhosis: A Randomized, Double-blind, Controlled Trial.
Long Chen, Chaoqun Zhao, Weili Yao, Wei Liu, Hua Zhang, Yongping Mu

J Clin Transl Hepatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis.
Qun Zhang, Shuaishuai Niu, Li Yang, Bingbing Zhu, Ke Shi, Yongping Mu

Front Cell Infect Microbiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDGF-BB is involved in HIF-1α/CXCR4/CXCR7 axis promoting capillarization of hepatic sinusoidal endothelial cells.
Jing Fang, Qiang Ji, Siqi Gao, Zhun Xiao, Wei Liu, Yongping Mu

Heliyon· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gypenosides ameliorate ductular reaction and liver fibrosis inhibition of hedgehog signaling.
Yonghong Hu, Xiaoli He, Xiaoxi Zhou, Yue Liang, Yadong Fu, Yongping Mu

Front Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis